Jun J, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Alzheimer's Disease Genetics Consortium. Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes. Arch Neurol. 2010 Aug 9;1(1):1-20.
Recommends
Please login to recommend the paper.
Comments
Cardiff University
Last year we published a GWAS of AD, and, together with an independent study, identified CLU, PICALM, and CR1 as susceptibility loci for Alzheimer disease (see Harold et al., 2009 and Lambert et al., 2009). These associations are replicated in the present study by Gyungah Jun and colleagues of the Alzheimer's Disease Genetics Consortium (ADGC), and together with similar recent studies (see Carrasquillo et al., 2010 and Corneveaux et al., 2010), provide additional confirmation that these are genuine susceptibility loci.
However, Jun et al. also report a significant ApoE-PICALM statistical interaction such that the significant association at the PICALM locus is predominantly observed in ApoE4 carriers. This is in contrast with the results from our GWAS, where no significant interaction with ApoE was observed (Stage1 sample: ApoE4 x PICALM rs3851179 interaction term P = 0.83; Stage 2 sample: P = 0.25). Restricting our analysis to the subset of individuals with available ApoE genotypes, our results for rs3851179 without adjustment for ApoE are: Stage 1 P = 6.4 x 10-5, OR = 0.85; Stage 2 P = 0.012, OR = 0.88); when adjusted for ApoE, the significance is only slightly reduced (Stage 1 P = 5.7 x 10-4, OR = 0.86; Stage 2 P = 0.049, OR = 0.90). Moreover, Carrasquillo et al. (2010) report significant association of rs3851179 with AD after ApoE adjustment (P = 1.3 x 10-5, OR = 0.80), and report that the results “stay essentially the same when no covariates are used, (i.e., when no adjustment is made for sex, age, and ApoE4 status).”
Thus, the putative ApoE-PICALM epistatic interaction does not appear to be consistent across the datasets examined to date, although the intriguing possibility that ApoE and PICALM are involved in a common pathogenic pathway warrants further investigation.
References:
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009 Oct;41(10):1088-93. PubMed.
Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, , de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanché H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alpérovitch A, Lathrop M, Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009 Oct;41(10):1094-9. PubMed.
Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol. 2010 Aug;67(8):961-4. PubMed.
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O'Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010 Aug 15;19(16):3295-301. PubMed.
Make a Comment
To make a comment you must login or register.